Trials / Recruiting
RecruitingNCT06580782
Calcium Carbonate to Augment Labor Contractions
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.
Detailed description
This study plans to study the acceptance and safety of using calcium carbonate as an medicine to help the labor induction process. The study aims to find if the use of calcium carbonate will lead to better labor contractions and increase the percentage of vaginal deliveries and improve delivery outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium Carbonate 500 MG | Calcium Carbonate 500mg, orally, every 4 hours. |
| DRUG | Standard Dose Synthetic Pitocin | The participant will receive thestandard-dose synthetic oxytocin for labor induction or augmentation. |
Timeline
- Start date
- 2024-11-18
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-08-30
- Last updated
- 2025-10-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06580782. Inclusion in this directory is not an endorsement.